FindTrial
Sign In

Retrospective study of FSH Pharmacogenomics and Population pharmacokinetics in Controlled ovarian hyperstimulation process of IVF-ICSI

The FSH individualized administration based on Pharmacogenomics and Population pharmacokinetics

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2100049142
Enrollment
Unknown
Registered
2021-07-23
Start date
2021-09-01
Completion date
Unknown
Last updated
2022-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

infertility

Interventions

Case series:None

Sponsors

The affiliated reproductive hospital of China Medical University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: 1. Aged 20 to 40 years; 2. IVF /ICSI-ET was carried out during clinical treatment; 3. Treated with FSH for more than 5 days, and at least one reliable FSH level was assayed during ovulation induction; 4. The clinical data was comprehensive and reliable.

Exclusion criteria

Exclusion criteria: 1. FSH was not used for ovulation induction during clinical treatment; 2. Patients had missing basic information and the clinical data was incomplete; 3. The patient was over 40 years old; 4. The process of ovulation induction was less than 5 days; 5. FSH level was not monitored during ovulation induction.

Design outcomes

Primary

MeasureTime frame
follicle stimulating hormone concentration;weight;Age;Renal function;Liver function;estradio level;oocyte number;types of gene polymorphism;—

Secondary

MeasureTime frame
anti-Müllerian hormone level;Antral Follicle Counting;—

Countries

China

Contacts

Public ContactSui Yang

The affiliated reproductive hospital of China Medical University

suiyang2014@163.com+86 13940066656

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 10, 2026